
Keywords: AboA; abobotulinumtoxinA; BoNT; botulinum neurotoxin; DyT; dystonic tremor; EMG; electromyography; ET; essential tremor; IncoA; incobotulinumtoxinA; NIHCGC; National Institutes of Health Collaborative Genetic Criteria; OL; open label; OnaA; onabotulinumto